ArticleOncogene2022

A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.

Hassan Yousefi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.